Skip to main content
Erschienen in: Reactions Weekly 1/2022

01.11.2022 | Case report

Multiple drugs

Lack of efficacy: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2022

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Dinges SS, et al. In severe juvenile-onset recurrent respiratory papillomatosis of a 10-year-old, systemic bevacizumab is highly effective and well tolerated. Klinische Padiatrie 234: 324-325, No. 5, Sep 2022. Available from: URL: http://doi.org/10.1055/s-0042-1754462 [abstract] Dinges SS, et al. In severe juvenile-onset recurrent respiratory papillomatosis of a 10-year-old, systemic bevacizumab is highly effective and well tolerated. Klinische Padiatrie 234: 324-325, No. 5, Sep 2022. Available from: URL: http://​doi.​org/​10.​1055/​s-0042-1754462 [abstract]
Metadaten
Titel
Multiple drugs
Lack of efficacy: case report
Publikationsdatum
01.11.2022
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2022
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-022-28697-3

Weitere Artikel der Ausgabe 1/2022

Reactions Weekly 1/2022 Zur Ausgabe

Case report

Ciclosporin